US2008152739A1PendingUtilityA1

Treating a buttock deformity

Assignee: ALLERGAN INCPriority: Sep 3, 2004Filed: Mar 4, 2008Published: Jun 26, 2008
Est. expirySep 3, 2024(expired)· nominal 20-yr term from priority
Inventors:Eric R. First
A61P 43/00A61K 8/64C12Y 304/24069A61K 38/4893A61K 2800/91A61P 21/00A61Q 19/00A61K 38/46A61K 39/02
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for treating a buttock deformity or for preventing development of a buttock deformity by local administration of a Clostridial toxin, such as a botulinum neurotoxin, to a buttock deformity or to the vicinity of a buttock deformity.

Claims

exact text as granted — not AI-modified
1 . A method for treating an arthrogenic inhibition of a gluteus maximus, the method comprising the steps of (a) administering a botulinum toxin into a buttock and (b) administering a botulinum toxin into a joint, thereby treating the arthrogenic inhibition. 
     
     
         2 . The method of  claim 1 , wherein the botulinum toxin is selected from the group consisting of botulinum toxin types A, B, C, D, E, F and G. 
     
     
         3 . The method of  claim 1 , wherein the botulinum toxin is a botulinum toxin type A. 
     
     
         4 . The method of  claim 1 , wherein the botulinum toxin is administered in an amount of between about 1 unit and about 3,000 units. 
     
     
         5 . The method of  claim 1 , wherein the buttock is a gluteus maximus ipsilateral to the arthrogenic inhibition. 
     
     
         6 . The method of  claim 1 , wherein the buttock is a gluteus medius contralateral to the arthrogenic inhibition. 
     
     
         7 . The method of  claim 1 , wherein the joint is a sacroiliac joint. 
     
     
         8 . A method for treating an arthrogenic inhibition of a gluteus maximus, the method comprising the steps of administering between 1 and about 3,000 units of botulinum toxin type A to (a) a gluteus maximus ipsilateral to the arthrogenic inhibition, (b) a gluteus medius contralateral to the arthrogenic inhibition, and (c) to a sacroiliac joint, thereby treating the arthrogenic inhibition of the gluteus maximus.

Join the waitlist — get patent alerts

Track US2008152739A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.